| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061468A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| 07/07/2005 | WO2005061459A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | WO2005061438A1 Method for producing optically active cycloalkylidene bisoxazoline compound and intermediate thereof |
| 07/07/2005 | WO2005061427A2 Method for the production of substituted 2-(phenoxymethyl)-benzoic acids |
| 07/07/2005 | WO2005060456A2 Method for treating adamts-5-associate disease |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
| 07/07/2005 | US20050148641 2-Methylthiazolidine-2,4-dicarboxylic acid and salts thereof for the treatment of neurodegenerative diseases |
| 07/07/2005 | US20050148576 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 07/07/2005 | US20050148041 Sandwich assay kits for detecting shigatoxin ctx3c |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050145831 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals |
| 07/07/2005 | CA2550627A1 Method for the production of substituted 2-(phenoxymethyl)-benzoic acids |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548513A1 Biaryl sulfonamides and methods for using same |
| 07/07/2005 | CA2547575A1 Method for treating adamts-5-associated disease |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549713A1 Synergistic uv absorber combination |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1549283A1 Merocyanine derivatives for cosmetic use |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN1636006A Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/06/2005 | CN1635888A 2-methylthiazolidine-2, 4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 07/06/2005 | CN1634898A Process for producing 4-(p-chloro phenyl)-2-trifluoro methyl-3-oxazole-5-one |
| 07/06/2005 | CN1209678C Silver halide photographic emulsion contg. methylidyne compound, and photographic material using said emulsion |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 06/30/2005 | WO2005058886A1 Novel oxazolidinone derivatives |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058818A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process |
| 06/30/2005 | WO2005058810A1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
| 06/30/2005 | WO2005000852A3 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | US20050143582 Method for producing substituted 3-phenylamino-propane-1,2-diols |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/29/2005 | EP1548012A2 Method of preparation of phenylenebisoxazolines. |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1546124A1 Process for preparing substituted phenoxy-acetic acids from phenols |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1545532A2 Heterocyclic compounds |
| 06/29/2005 | EP1545517A1 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633292A Cotherapy with an oxazolidinone and a vitamin B |
| 06/29/2005 | CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists |
| 06/29/2005 | CN1208327C Process for preparing S, Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 06/28/2005 | US6911549 Method of preparing a taxol derivative |
| 06/28/2005 | US6911510 Azlactones chain transfer agent for reversible addition-fragmentation chain transfer (RAFT) polymerization and telechelic homo or copolymer formed thereby |
| 06/28/2005 | US6911459 Pharmaceutical composition |
| 06/28/2005 | US6911448 Piperazine and piperidine compounds |
| 06/23/2005 | WO2005056538A1 Oxazole derivatives of tetracyclines |
| 06/23/2005 | WO2005056537A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | WO2005056536A1 Antidiabetic agents which exhibit activity against ppar |
| 06/23/2005 | WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005040129A3 Ccr3 receptor antagonists |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137404 Azlactone compound and method for preparation thereof |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke |
| 06/23/2005 | DE19505932B4 Verfahren zur Herstellung von Oxazolidinonen, neue Oxazolidinone sowie Verwendung von Oxazolidinonen A process for preparing oxazolidinones, oxazolidinones, as well as use of new oxazolidinones |
| 06/23/2005 | CA2549355A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2546895A1 Oxazole derivatives of tetracyclines |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1282619B1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use |
| 06/21/2005 | US6909005 One post synthesis of 2-oxazolidinone derivatives |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908884 For agriculture/horticulture/crops |
| 06/16/2005 | WO2005054194A1 A method for the preparation of (2s, 3ar, 7as)-octahydro-1h-indole-2-carboxylic acid as key intermediate in the preparation of trandolapril by reacting a cyclohexyl aziridine with a dialkyl malonate |
| 06/16/2005 | WO2005053631A1 Microcapsules with uv filter activity and process for producing them |
| 06/16/2005 | US20050131038 Process for the preparation of valsartan and intermediates thereof |
| 06/16/2005 | US20050131018 Acetylene derivatives as inhibitors of histone deacetylase |
| 06/16/2005 | US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/16/2005 | US20050130970 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters |
| 06/15/2005 | EP1541564A1 Five-membered heterocyclic compounds |
| 06/15/2005 | EP1541552A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process |
| 06/15/2005 | EP1539685A1 Mcp-1 receptor antagonists and method of use thereof |
| 06/15/2005 | EP1539319A1 Crystallization system utilizing atomization |
| 06/15/2005 | EP1539147A1 Methods of treating microbial infections in humans and animals |
| 06/15/2005 | EP1349856B1 Isoindolin-1-one glucokinase activators |
| 06/15/2005 | EP1255754B1 Linezolid-crystal form ii |
| 06/15/2005 | EP1126843A4 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |